Literature DB >> 24997147

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.

Gabriel Brisou1, Aurélie Verney2, Thomas Wenner2, Lucile Baseggio3, Pascale Felman4, Evelyne Callet-Bauchu5, Bertrand Coiffier6, Françoise Berger7, Gilles Salles1, Alexandra Traverse-Glehen8.   

Abstract

Entities:  

Keywords:  autoimmunity; immunoglobulin genes; marginal zone lymphoma

Mesh：

Substances：

Year:  2014        PMID： 24997147      PMCID： PMC4181269          DOI： 10.3324/haematol.2014.107680

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.

Authors:  Felipe Suarez; Olivier Lortholary; Olivier Hermine; Marc Lecuit
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

2.  Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.

Authors:  V Bikos; E Stalika; P Baliakas; N Darzentas; Z Davis; A Traverse-Glehen; A Dagklis; G Kanellis; A Anagnostopoulos; A Tsaftaris; M Ponzoni; F Berger; P Felman; P Ghia; T Papadaki; D Oscier; C Belessi; K Stamatopoulos
Journal:  Leukemia       Date:  2012-06-18       Impact factor: 11.528

3.  Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.

Authors:  Alexandra Traverse-Glehen; Emmanuel Bachy; Lucile Baseggio; Evelyne Callet-Bauchu; Sophie Gazzo; Aurélie Verney; Sandrine Hayette; Laurent Jallades; Martine Ffrench; Gilles Salles; Bertrand Coiffier; Pascale Felman; Francoise Berger
Journal:  Histopathology       Date:  2013-05       Impact factor: 5.087

4.  B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis.

Authors:  V J Craig; S B Cogliatti; I Arnold; C Gerke; J-E Balandat; T Wündisch; A Müller
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528

5.  Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

Authors:  Alexandra Traverse-Glehen; Frédéric Davi; Elsa Ben Simon; Evelyne Callet-Bauchu; Pascale Felman; Lucile Baseggio; Sophie Gazzo; Catherine Thieblemont; Carole Charlot; Bertrand Coiffier; Françoise Berger; Gilles Salles
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

6.  Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.

Authors:  V Bikos; N Darzentas; A Hadzidimitriou; Z Davis; S Hockley; A Traverse-Glehen; P Algara; A Santoro; D Gonzalez; M Mollejo; A Dagklis; F Gangemi; D S Bosler; G Bourikas; A Anagnostopoulos; A Tsaftaris; E Iannitto; M Ponzoni; P Felman; F Berger; C Belessi; P Ghia; T Papadaki; A Dogan; M Degano; E Matutes; M A Piris; D Oscier; K Stamatopoulos
Journal:  Leukemia       Date:  2012-01-06       Impact factor: 11.528

7.  Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.

Authors:  Vanessa J Craig; Isabelle Arnold; Christiane Gerke; Minh Q Huynh; Thomas Wündisch; Andreas Neubauer; Christoph Renner; Stanley Falkow; Anne Müller
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

8.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

Authors:  Olivier Hermine; François Lefrère; Jean-Pierre Bronowicki; Xavier Mariette; Katayoun Jondeau; Virginie Eclache-Saudreau; Béatrice Delmas; Françoise Valensi; Patrice Cacoub; Christian Brechot; Bruno Varet; Xavier Troussard
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

Review 9.  Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.

Authors:  K E Smedby; J Askling; X Mariette; E Baecklund
Journal:  J Intern Med       Date:  2008-12       Impact factor: 8.989

Review 10.  Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis.

Authors:  Felipe Suarez; François Lefrere; Caroline Besson; Olivier Hermine
Journal:  Dig Liver Dis       Date:  2007-09       Impact factor: 4.088
View more
  4 in total

1.  Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.

Authors:  Shuhua Yi; Yuting Yan; Wenjie Xiong; Rui Lv; Zhen Yu; Wei Liu; Enbin Liu; Heng Li; Huimin Liu; Zengjun Li; Gang An; Yan Xu; Kun Ru; Dehui Zou; Lugui Qiu
Journal:  Oncotarget       Date:  2017-10-19

Review 2.  Effective management strategies for patients with marginal zone lymphoma.

Authors:  Cecilia B Rosand; Kelly Valla; Christopher R Flowers; Jean L Koff
Journal:  Future Oncol       Date:  2017-12-20       Impact factor: 3.404

3.  Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.

Authors:  Matteo Sbattella; Andrea Zanichelli; Paolo Ghia; Valter Gattei; Chiara Suffritti; Thomas Teatini; Marco Cicardi; Roberto Castelli
Journal:  Med Oncol       Date:  2018-08-02       Impact factor: 3.064

4.  Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas.

Authors:  María García-Álvarez; Sara Alonso-Álvarez; Isabel Prieto-Conde; Cristina Jiménez; M Eugenia Sarasquete; M Carmen Chillón; Alejandro Medina; Ana Balanzategui; Rebeca Maldonado; Alicia Antón; Noemí Puig; Marta Rodríguez; Oscar Blanco; Pilar Tamayo; Verónica González-Calle; Alejandro Martín; Ramón García-Sanz; Marcos González; M Dolores Caballero; Miguel Alcoceba
Journal:  Blood Cancer J       Date:  2019-06-17       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.